Back to Newsroom
Back to Newsroom

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IRTC, CLOV and APA

Thursday, 25 February 2021 09:00 AM

The Klein Law Firm

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

iRhythm Technologies, Inc. (NASDAQ:IRTC)
Class Period: August 4, 2020 - January 28, 2021
Lead Plaintiff Deadline: April 2, 2021

The IRTC lawsuit alleges that throughout the class period, iRhythm Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) iRhythm’s business would suffer as a result of the CMS’ rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and (4) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times

Learn about your recoverable losses in IRTC: http://www.kleinstocklaw.com/pslra-1/irhythm-technologies-inc-loss-submission-form?id=13129&from=1

Clover Health Investments, Corp. (NASDAQ:CLOV)
Class Period: October 6, 2020 - February 3, 2021
Lead Plaintiff Deadline: April 6, 2021

The complaint alleges that during the class period Clover Health Investments, Corp. made materially false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover’s sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover’s
subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover’s software was in fact rudimentary; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in CLOV: http://www.kleinstocklaw.com/pslra-1/clover-health-investments-corp-loss-submission-form?id=13129&from=1

Apache Corporation (NASDAQ:APA)
Class Period: September 7, 2016 - March 13, 2020
Lead Plaintiff Deadline: April 26, 2021

According to the complaint, Apache Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Apache intentionally used unrealistic assumptions regarding the amount and composition of available oil and gas in Alpine High; (ii) Apache did not have the proper infrastructure in place to safely and/or economically drill and/or transport those resources even if they existed in the amounts purported; (iii) these misleading statements and omissions artificially inflated the value of the Company’s operations in the Permian Basin; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in APA: http://www.kleinstocklaw.com/pslra-1/apache-corporation-loss-submission-form?id=13129&from=1

The Klein Law Firm, Thursday, February 25, 2021, Press release picture

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: